Weedstocks Newswire Feed
Reports First Ever Revenue From Operations
TORONTO, Nov. 8, 2018 /CNW/ - Newstrike Brands Ltd. (TSXV:HIP) (the "Company" or "HIP") announced today the achievement of significant milestones and a strengthened financial position for the three and nine months ended September 30, 2018. The Company's wholly-owned subsidiary, UP Cannabis Inc. ("Up Cannabis"), is a licensed producer of cannabis and related products under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company's interim financial statements and management's discussion and analysis for the three and nine months ended September 30, 2018 and its amended and restated interim financial statements and management's discussion and analysis for the three and nine months ended September 30, 2017 (the "Amended Statements") are available on SEDAR at www.sedar.com.
THIRD QUARTER ENDED SEPTEMBER 30, 2018 HIGHLIGHTS
SELECTED SUMMARY OF QUARTERLY RESULTS
SMITHS FALLS, ON, Nov. 8, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) today announced that it has entered into a multi-year agreement with The Brink's Company (NYSE: BCO) through its Brink's Canada subsidiary to provide secure logistics and cash management services for Canopy Growth's domestic and international cannabis operations.
The Brink's Company is the global leader in total cash management, secure route-based logistics and payment solutions and its global infrastructure will allow Canopy Growth to scale efficiently as its logistics needs become increasingly complex.
"Brinks' reputation as a trusted industry leader has been earned by providing reliable secure transport services for over 90 years in Canada," said Mark Zekulin, President and Co-CEO, Canopy Growth. "As a cannabis producer with growing national and international needs, we are proud to enter into this agreement and look forward to working with Brink's to consistently deliver a variety of high-quality cannabis products to our retail locations and affiliates across the country."
"The cannabis industry requires at-scale security solutions in order to continue on a trend of global growth, and Brink's is uniquely positioned to provide these solutions," said Doug Pertz, Brink's President and CEO. "Our partnership with Canopy Growth, the leading producer and exporter of cannabis, diversifies our customer base and leverages BGS' global network of secure logistics operations. We look forward to building a strong relationship with Canopy Growth as it grows throughout Canada and continues to enter new international markets."
In addition to providing secure logistics and cash management services, Canopy Growth and Brink's will develop a cross-selling program that enables Brink's to provide services to Canopy Growth's affiliated growers and retail customers. Canopy Growth's international transportation and security needs will be provided by Brink's Global Services ("BGS"), a Brink's subsidiary that provides secure logistics for international shipments of high-value commodities.
Wayland Group Announces Closing of Over-Allotment Option for Additional Gross Proceeds of $7.5 Million
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that, further to its press release dated October 31, 2018 and in connection with its previously announced bought deal financing, it has issued an additional 4,552,500 Units (the “Units”) at a price of $1.65 per Unit (the “Offering Price”) for total gross proceeds of $7,511,625, pursuant to the exercise in full of the Underwriters’ over-allotment option. The aggregate gross proceeds of the Offering, including the over-allotment option, total $57,589,125 (the “Offering”).
The Offering was completed by a syndicate of underwriters led by Canaccord Genuity Corp. and including Haywood Securities Inc., AltaCorp Capital Inc., and GMP Securities L.P. (collectively, the “Underwriters”).
The securities offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
The BEAST can process up to 1,000 kg of Biomass Per Day
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Quadron Cannatech Corporation (the “Company” or “Quadron”) – (CSE: QCC), is pleased to introduce its fully automated, touch screen control continuous flow Ethanol Extractor System, the “BEAST”.
The BEAST is in its final stage of development and innovative engineering which culminated in this extraction system which can process massive amounts of biomass for the cannabis industry. The price of the BEAST, depending on the model and options, will range from $1.5 million to $2.25 million.
Some Key BEAST Advantages
Rosy Mondin, CEO of Quadron commented, “We are excited about the development of the BEAST, the first of its kind in Canada. The Beast is a high efficiency ethanol extraction system which represents the end result of extensive research and development. The Beast has the capability of providing licensed producers the ability to process extraordinary amounts of biomass per day.”
Nutritional High Comments on Results of Midterm Elections and Key Regulatory Developments in US Cannabis Industry
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) wishes to provide comments on the results of the Midterm Elections and key regulatory developments in the US.
The Midterms US voters delivered a split verdict in midterm elections for Congress yesterday evening. The Democrats secured a majority in the House of Representatives while Republicans have further expanded their majority in the Senate. Overall, Democrats have surpassed the 218 seats needed for a House majority while the Republicans increased their seats in the Senate with 51 seats out of 100.
A Good Result for the Cannabis Sector Senior management at Nutritional High view the results as catalyst for the cannabis sector to reinforce the notion that cannabis in the US has the tipping point on its way to eventual full legal status. Clarity on “banking rules”, according to Bloomberg, could help to close the valuation gap between US stocks and their Canadian counterparts. On the other hand, pro-cannabis legislation would still have to pass the Senate and the Executive Branch but now with recently embattled Attorney Jeff Sessions resigning under pressure from Trump, it seems the path to legalization just got a little clearer.
The STATES Act and Opportunities for Continued Growth With divided congressional power, there will be opportunity for bi-partisanship on a number of issues including the Strengthening the Tenth Amendment Through Entrusting States Act, S. 3032 (the "STATES Act"), This long-awaited piece of legislation would protect individuals working in cannabis sectors from federal prosecution. The STATES Act was introduced in June 2018 through bi-partisan efforts initiated by Senator Cory Gardner (Republican from Colorado) together with Senator Elizabeth Warren (Democrat from Massachusetts). Senator Elizabeth Warren won re-election which ensures she will push the change to federal law regarding cannabis.
In addition, constituents of Michigan voted to legalize recreational marijuana, making Michigan the first state in the Midwest to do so and the 10th in the US overall demonstrating growing sentiment amongst Americans towards legalization. Voters in Missouri and Utah approved ballot measures legalizing cannabis for medical use, making their states the 31st and 32nd to do so giving confidence to other states to follow suit. However, voters in North Dakota did not pass an initiative to legalize recreational use. The results are largely positive, indicating continuing and growing opportunities the US.
TORONTO, Nov. 8, 2018 /CNW/ - Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce the readiness of eight product lines in eco-friendly packaging for medical cannabis patients.
PureSinse will begin sales to medical patients soon after Health Canada has granted it a Sales License, which is anticipated in the coming weeks. PureSinse is committed to providing medical cannabis patients with medical cannabis products despite the high demands of the legal adult markets, which also represents a higher margin sales channel for the Company.
The PureSinse product line, that includes eight stock keeping units (SKUs) of newly launched and co-branded products, is enhanced by the Company's commitment to a clinical and research-driven approach, true to its pharmacy and physician roots. With elegant sustainable packaging, PureSinse looks to provide its clientele with an exceptional customer experience at all levels of its service and product offerings.
Cheryl Pim, Director of New Product Development, says "the PureSinse brand is focused on patients. We will be tracking clinical outcomes through real-world studies to ensure our products lines are consistent, tailored and available. This consistency and dependability are what patients rely on for their medical needs. Our research and data-driven approach will ensure our products and methods also improve and evolve for the needs of patients over time."
Pure Global is also committed to reusable packaging and recyclable options and this "sets us apart," says Malay Panchal, CEO of Pure Global, "we have a plan to be sustainable and tightly linked to the clinical community. We are committed to outcomes that help patients on a consistent and ongoing basis."
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Canada House Clinics, the clinic division of Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV), is pleased to announce it has entered into a strategic partnership with Peak Pharma Solutions, leveraging its new clinic branding and organizational changes to position itself for accelerated growth.
Canada House Clinics’ superior clinic operation, trusted by physicians for medical cannabis referrals, will be able to access proven pharmaceutical industry sales experts to educate more physicians about the benefits and advantages of referring patients to CHC.
“We are leveraging our national reach to ramp up our growth,” said Canada House Clinics President Alex Kroon. “We selected Peak Pharma Solutions (Peak) based on the vast experience of its senior team in successfully delivering physician detailing programs. We look forward to starting our first physician campaign in a major city market after the holiday season.”
Peak leadership has spent over 20 years implementing sales solutions and managing successful pharmaceutical sales forces. “We are excited to be supporting Canada House Clinics to educate physicians on cannabinoid therapy and why CHC is their best choice,” said Managing Partners Jennifer Meldrum and Richard Adamson. “This program will be on the leading edge for cannabis clinics and will address a key area many physicians struggle with.”
KITCHENER, Ontario, Nov. 08, 2018 (GLOBE NEWSWIRE) -- James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA), is pleased to announce that on November 2, 2018, following a building inspection, the Corporation received a permit for partial occupancy (the “Permit”) of its second facility (“JWC 2”). Since receiving the main building permits in July 2018, JWC has been working at a rapid pace of construction, as part of the Corporation’s plan to bring JWC 2 to a high-level of production in 2019.
The Permit is an essential step towards bringing plants into cultivation at JWC2, as it allows the Corporation to make the necessary preparations for all aspects of cultivation activities throughout the rooms currently being developed during the first phase of construction. JWC anticipates that the first phase of construction of JWC 2, once complete, will include the following: one large vegetative growth room, eight flowering rooms, one trimming and processing room, one drying room, one destruction room, one secure storage room, and one equipment manufacturing shop. Additionally, JWC intends to submit applications in the coming weeks for occupancy of the office space at JWC 2, which has been under construction concurrently. The custom designed head office space is intended to further support the ongoing expansion of JWC and will provide space for additional staff to manage and support JWC’s cultivation operations.
JWC 2 is designed to provide a total of approximately 345,000 square feet of state-of-the-art cultivation space. It is anticipated that this retro-fitted facility will feature more than 130 production rooms at the completion of construction sometime in 2019. Like the Corporation’s existing pilot facility, JWC 2 will also utilize advanced research and cultivation methods, including the Corporation’s proprietary aeroponic GrowthSTORM™ system. Upon completion of the construction of JWC 2, the Corporation anticipates that it will employ more than 450 employees.
About James E. Wagner Cultivation Corporation
JWC’s wholly-owned subsidiary is a Licensed Producer under the Cannabis Regulations (formally the Access to Cannabis for Medical Purposes Regulations (“ACMPR”)) and JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary aeroponic platform named GrowthStormTM. JWC was founded as a family company, based on family values. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca
VANCOUVER, Nov. 8, 2018 /CNW/ - Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF:US) (the "Company" or "Koios"), is pleased to announce the Company will be initiating a clinical study into the impact of CBD on the human brain.
Koios is already conducting a clinical trial on the impact of its nootropic supplements on the human brain, and released preliminary results on Oct. 9, 2018. Koios beverages and supplements contain a proprietary formula of nootropic, brain-enhancing nutrients.
The trial involved mapping the activity of the brain before and after subjects consumed Koios nootropic supplements.
Full clinical brain scans on Koios users show changes in brain activity in three main areas, all of which indicate improved cognitive function.
"The findings, although preliminary, are better than we could have expected," said Chris Miller, CEO of the Company. "Changes in the type of brain activity that we are seeing between the baseline that was mapped at the start of the study, and the effect on participants after several months of consuming our beverages, could have many positive implications."
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
LAS VEGAS, Nov. 8, 2018 /CNW/ - Planet 13 Holdings Inc. ("Planet 13" or the "Company") (CSE:PLTH) (OTCQB:PLNHF) is pleased to announce that it has amended the terms of its previously announced bought deal offering of units (the "Units") of the Company (the "Offering"). Under the amended terms of the Offering, a syndicate of underwriters (the "Underwriters") led by Beacon Securities Limited ("Beacon") has agreed to purchase, on a bought deal basis, 8,335,000 Units at a price of $3.00 per Unit (the "Offering Price") for aggregate gross proceeds to the Company of $25,005,000. (All figures are in Canadian dollars unless otherwise stated).
Each Unit shall consist of one common share (a "Common Share") in the capital of the Company and one-half (1/2) of one common share purchase warrant (each whole warrant, a "Warrant") of the Company. Each whole Warrant shall entitle the holder thereof to acquire one Common Share at an exercise price per Common Share of $3.75 for a period of 36 months from the Closing Date (as defined below). The Warrants may be accelerated by the Company, at its sole option, at any time in the event that the volume-weighted average closing price of the Common Shares on the Canadian Securities Exchange is greater than or equal to $5.00 for a period of 20 consecutive trading days, by giving notice to the holders thereof and, in such case, the Warrants will expire at 4:00 pm (Toronto time) on the earlier of: (i) the 30th day after the date on which such notice is given by the Company in accordance with the terms of the Warrants, and (ii) the actual expiry date of the Warrants.
The closing of the Offering is expected to occur on or about December 4, 2018 (the "Closing Date") and is subject to the completion of formal documentation and receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. The net proceeds from the Offering will be used for working capital and general corporate purposes.
The Company has granted the Underwriters an option (the "Over-Allotment Option"), exercisable, in whole or in part, by Beacon, on behalf of the Underwriters, giving notice to the Company at any time and from time to time up to 30 days following the Closing Date, to purchase, or to find substituted purchasers for, up to an additional number of Units equal to 15% of the number of Units sold pursuant to the Offering at the Offering Price to cover over-allotments, if any, and for market stabilization purposes.